BR0311585A - Sistema de fornecimento de drogas, método para administrar uma droga oftálmica a um paciente, kit, uso do mesmo, método para preparar o sistema de fornecimento de drogas, e, artigo de fabricação - Google Patents
Sistema de fornecimento de drogas, método para administrar uma droga oftálmica a um paciente, kit, uso do mesmo, método para preparar o sistema de fornecimento de drogas, e, artigo de fabricaçãoInfo
- Publication number
- BR0311585A BR0311585A BR0311585-2A BR0311585A BR0311585A BR 0311585 A BR0311585 A BR 0311585A BR 0311585 A BR0311585 A BR 0311585A BR 0311585 A BR0311585 A BR 0311585A
- Authority
- BR
- Brazil
- Prior art keywords
- delivery system
- drug delivery
- drug
- administering
- kit
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/04—Contact lenses for the eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Ophthalmology & Optometry (AREA)
- Nanotechnology (AREA)
- Biomedical Technology (AREA)
- General Physics & Mathematics (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Eyeglasses (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"SISTEMA DE FORNECIMENTO DE DROGAS, MéTODO PARA ADMINISTRAR UMA DROGA OFTáLMICA A UM PACIENTE, KIT, USO DO MESMO, MéTODO PARA PREPARAR O SISTEMA DE FORNECIMENTO DE DROGAS, E, ARTIGO DE FABRICAçãO". Um sistema de fornecimento de drogas compreendendo uma lente de contato apresentando dispersa na mesma, como nanopartículas apresentando um tamanho de partículas inferior a cerca de 50 nm, uma droga encapsulada em um material a partir do qual referida droga oftálmica é capaz de difusão em, e migração através de, referida lente de contato e para o interior da película lacrimal posterior à lente quando referida lente de contato é colocada no olho.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38557102P | 2002-06-05 | 2002-06-05 | |
PCT/US2003/017736 WO2003103549A1 (en) | 2002-06-05 | 2003-06-05 | Ophthalmic drug delivery system |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0311585A true BR0311585A (pt) | 2005-05-10 |
Family
ID=29736101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0311585-2A BR0311585A (pt) | 2002-06-05 | 2003-06-05 | Sistema de fornecimento de drogas, método para administrar uma droga oftálmica a um paciente, kit, uso do mesmo, método para preparar o sistema de fornecimento de drogas, e, artigo de fabricação |
Country Status (12)
Country | Link |
---|---|
US (1) | US7638137B2 (pt) |
EP (1) | EP1534202B1 (pt) |
JP (1) | JP4448441B2 (pt) |
KR (1) | KR20050037992A (pt) |
CN (1) | CN100369593C (pt) |
AT (1) | ATE424795T1 (pt) |
AU (1) | AU2003248624B2 (pt) |
BR (1) | BR0311585A (pt) |
CA (1) | CA2487940C (pt) |
DE (1) | DE60326597D1 (pt) |
HK (1) | HK1080349A1 (pt) |
WO (1) | WO2003103549A1 (pt) |
Families Citing this family (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
ES2349235T3 (es) * | 2001-12-21 | 2010-12-29 | Alcon, Inc. | Uso de nanopartículas inorgánicas sintéticas como vehículos para farmacos oftálmicos. |
US8071121B2 (en) * | 2002-06-05 | 2011-12-06 | University Of Florida Research Foundation, Incorporated | Dispersions of microemulsions in hydrogels for drug delivery |
TWI347847B (en) * | 2003-08-20 | 2011-09-01 | Santen Pharmaceutical Co Ltd | Drug delivery system for sub-tenon administration of fine particles |
DE602004027553D1 (de) * | 2004-08-03 | 2010-07-15 | Agency Science Tech & Res | Polymer mit miteinander verbundenen poren zur arzneistoffzufuhr und verfahren |
US20060057216A1 (en) * | 2004-09-15 | 2006-03-16 | Salamone Joseph C | Low-obscuration image transmitting particulate ocular therapeutic formulations |
ES2669585T3 (es) | 2004-10-29 | 2018-05-28 | The Regents Of The University Of California | Micropartículas porosas de silicio para la entrega de fármaco para el ojo |
US8349351B2 (en) * | 2005-02-04 | 2013-01-08 | Auburn University | Contact drug delivery system |
US9238003B2 (en) | 2005-02-04 | 2016-01-19 | Auburn University | Extended or continuous wear silicone hydrogel contact lenses for the extended release of comfort molecules |
US8388995B1 (en) | 2006-02-03 | 2013-03-05 | Auburn University | Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform |
US8349352B2 (en) * | 2005-02-04 | 2013-01-08 | Auburn University | Therapeutic contact lenses with anti-fungal delivery |
WO2007005249A2 (en) * | 2005-06-29 | 2007-01-11 | Hyperbranch Medical Technology, Inc. | Nanoparticles and dendritic-polymer-based hydrogels comprising them |
WO2007011708A2 (en) | 2005-07-15 | 2007-01-25 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
WO2007054822A2 (en) * | 2005-09-30 | 2007-05-18 | Galderma S.A. | Use of at least one avermectin or milbemycin in the treatment of ophthalmic pathologies |
BRPI0619938A2 (pt) * | 2005-12-16 | 2011-10-25 | Univ Kansas | nano agrupamentos para envio de terapêuticos |
US20070184076A1 (en) * | 2006-02-07 | 2007-08-09 | Unger Evan C | Liquid-filled nanodroplets for anti-cancer therapy |
WO2007139808A2 (en) * | 2006-05-25 | 2007-12-06 | Ayyala Ramesh S | Device for delivery of antifibrotic agents & method |
US7793535B2 (en) * | 2006-10-31 | 2010-09-14 | Johnson & Johnson Vision Care, Inc. | Devices and methods to simulate an ocular environment |
US20080138408A1 (en) * | 2006-11-13 | 2008-06-12 | Siddharth Venkatesh | Drug delivery system and method |
EP2087020A4 (en) * | 2006-11-17 | 2010-11-24 | Agency Science Tech & Res | POROUS POLYMERIC MATERIAL COMPRISING A CROSS-LINING AGENT |
CA2679712C (en) | 2007-01-08 | 2016-11-15 | Micell Technologies, Inc. | Stents having biodegradable layers |
US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
US20080317822A1 (en) * | 2007-06-20 | 2008-12-25 | Nugene | Methods for Delivery of Nanosome Encapsulated Agents |
WO2009032266A2 (en) * | 2007-09-04 | 2009-03-12 | University Of Florida | Dispersions of microparticles and microgels in hydrogels for drug delivery |
US8480638B2 (en) * | 2007-10-04 | 2013-07-09 | Aciont, Inc. | Intraocular iontophoretic device and associated methods |
CN101181227B (zh) * | 2007-12-10 | 2012-05-30 | 沈阳药科大学 | 生物黏附性环孢素a固体脂质纳米粒原位凝胶制剂及其制备方法 |
EP2244760B8 (en) * | 2008-01-28 | 2022-07-20 | Implantica Patent Ltd. | An implantable drainage device |
CN102083397B (zh) | 2008-04-17 | 2013-12-25 | 米歇尔技术公司 | 具有生物可吸收层的支架 |
US9486431B2 (en) | 2008-07-17 | 2016-11-08 | Micell Technologies, Inc. | Drug delivery medical device |
CA2683467C (en) * | 2008-10-24 | 2016-01-26 | Jin Zhang | Contact lens integrated with a biosensor for detection of glucose and other components in tears |
EP2962682B1 (en) * | 2008-12-11 | 2018-03-28 | Massachusetts Institute Of Technology | Method of making a contact lens drug delivery device |
CA2751342C (en) * | 2009-01-29 | 2019-05-07 | Alnylam Pharmaceuticals, Inc. | Lipid formulations comprising cationic lipid and a targeting lipid comprising n-acetyl galactosamine for delivery of nucleic acid |
SG174464A1 (en) | 2009-03-19 | 2011-10-28 | Agency Science Tech & Res | Forming copolymer from bicontinuous microemulsion comprising monomers of different hydrophilicity |
US9981072B2 (en) | 2009-04-01 | 2018-05-29 | Micell Technologies, Inc. | Coated stents |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
US10105317B2 (en) | 2009-07-07 | 2018-10-23 | Anpac Bio-Medical Science Co., Ltd. | Method of drug delivery |
EP2453834A4 (en) | 2009-07-16 | 2014-04-16 | Micell Technologies Inc | MEDICAL DEVICE DISPENSING MEDICINE |
EP2498763A4 (en) | 2009-11-09 | 2015-10-07 | Spotlight Technology Partners Llc | HYDROGELS BASED ON POLYSACCHARIDE |
US8795727B2 (en) | 2009-11-09 | 2014-08-05 | Spotlight Technology Partners Llc | Fragmented hydrogels |
EP2531140B1 (en) | 2010-02-02 | 2017-11-01 | Micell Technologies, Inc. | Stent and stent delivery system with improved deliverability |
US8828246B2 (en) | 2010-02-18 | 2014-09-09 | Anpac Bio-Medical Science Co., Ltd. | Method of fabricating micro-devices |
WO2011106702A2 (en) | 2010-02-25 | 2011-09-01 | The Johns Hopkins University | Sustained delivery of therapeutic agents to an eye compartment |
US10413506B2 (en) | 2010-04-03 | 2019-09-17 | Praful Doshi | Medical devices including medicaments and methods of making and using same including enhancing comfort, enhancing drug penetration, and treatment of myopia |
NZ602673A (en) | 2010-04-03 | 2014-09-26 | Praful Doshi | Medical devices including medicaments and methods of making and using same |
US10232092B2 (en) | 2010-04-22 | 2019-03-19 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
CA2805631C (en) | 2010-07-16 | 2018-07-31 | Micell Technologies, Inc. | Drug delivery medical device |
US9327037B2 (en) | 2011-02-08 | 2016-05-03 | The Johns Hopkins University | Mucus penetrating gene carriers |
US10245178B1 (en) | 2011-06-07 | 2019-04-02 | Glaukos Corporation | Anterior chamber drug-eluting ocular implant |
TW201302244A (zh) | 2011-07-08 | 2013-01-16 | Univ Nat Chiao Tung | 載藥型隱形眼鏡及其製備方法 |
US10117972B2 (en) | 2011-07-15 | 2018-11-06 | Micell Technologies, Inc. | Drug delivery medical device |
US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
US9046699B2 (en) * | 2012-03-13 | 2015-06-02 | Johnson & Johnson Vision Care, Inc. | Dynamic fluid zones in contact lenses |
JP5883539B2 (ja) | 2012-03-16 | 2016-03-15 | ザ・ジョンズ・ホプキンス・ユニバーシティー | Hif−1阻害剤の送達のための放出制御製剤 |
EP2825207B1 (en) | 2012-03-16 | 2020-08-19 | The Johns Hopkins University | Non-linear multiblock copolymer-drug conjugates for the delivery of active agents |
US9533068B2 (en) | 2012-05-04 | 2017-01-03 | The Johns Hopkins University | Drug loaded microfiber sutures for ophthalmic application |
NZ705812A (en) | 2012-09-17 | 2018-08-31 | Pfizer | Process for preparing therapeutic nanoparticles |
MX363147B (es) * | 2012-09-17 | 2019-03-11 | Pfizer Inc Star | Nanoparticulas terapeuticas que comprenden un agente terapeutico y metodos para realizarlas y usarlas. |
KR101371685B1 (ko) * | 2012-10-30 | 2014-03-10 | 김선호 | 치료용 콘택트렌즈 |
CN103848852B (zh) * | 2012-11-28 | 2019-02-19 | 杨子剑 | 含有头孢菌素结构的新化合物以及制备方法和用途 |
WO2014124006A1 (en) | 2013-02-05 | 2014-08-14 | The Johns Hopkins University | Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof |
EP2967803B1 (en) | 2013-03-12 | 2023-12-27 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
WO2014186532A1 (en) | 2013-05-15 | 2014-11-20 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
EP3016637B1 (en) | 2013-07-04 | 2020-11-11 | Yeda Research and Development Co., Ltd. | Low friction hydrogels and hydrogel-containing composite materials |
PT3046584T (pt) | 2013-09-16 | 2017-09-18 | Astrazeneca Ab | Nanopartículas poliméricas terapêuticas e métodos para fabrico e uso das mesmas |
US9668916B2 (en) | 2013-11-04 | 2017-06-06 | Vance M. Thompson | Conjunctival cover and methods therefor |
WO2015066616A1 (en) * | 2013-11-04 | 2015-05-07 | Thompson Vance M | Conjunctival cover and methods therefor |
EP3511019B1 (en) | 2014-03-14 | 2020-10-14 | Pfizer Inc | Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same |
JP6655610B2 (ja) | 2014-05-29 | 2020-02-26 | グローコス コーポレーション | 制御された薬物送達機能を備えるインプラント及びそれを使用する方法 |
JPWO2015190604A1 (ja) * | 2014-06-12 | 2017-04-20 | 株式会社シード | 有機ナノチューブを含有する機能性高分子ゲル及びその製造方法 |
CN107073031B (zh) | 2014-06-15 | 2021-08-24 | 耶达研究及发展有限公司 | 利用水溶性聚合物和脂质/脂质体的表面处理 |
EP3179988A4 (en) | 2014-08-11 | 2018-11-14 | Board of Supervisors of Lousiana State University | Delivery of bioactive, nanoencapsulated antioxidants |
AU2016211696B2 (en) | 2015-01-27 | 2018-05-10 | The Johns Hopkins University | Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces |
US9869883B2 (en) | 2015-03-11 | 2018-01-16 | Vance M. Thompson | Tear shaping for refractive correction |
EP3103485A1 (en) * | 2015-06-11 | 2016-12-14 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Material comprising a polymer capable of forming a hydrogel and nanoparticles |
CN114533898A (zh) | 2015-07-09 | 2022-05-27 | 加利福尼亚大学董事会 | 融合脂质体包被的多孔硅纳米颗粒 |
WO2017040853A1 (en) | 2015-09-02 | 2017-03-09 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
US11564833B2 (en) | 2015-09-25 | 2023-01-31 | Glaukos Corporation | Punctal implants with controlled drug delivery features and methods of using same |
EP3442479A1 (en) | 2016-04-20 | 2019-02-20 | Harold Alexander Heitzmann | Bioresorbable ocular drug delivery device |
US10353220B2 (en) | 2016-10-17 | 2019-07-16 | Vance M. Thompson | Tear shaping for refractive correction |
CZ2016827A3 (cs) | 2016-12-23 | 2018-02-07 | Contipro A.S. | Oftalmologický prostředek |
EP3583177B1 (en) | 2017-02-16 | 2020-12-23 | Momentive Performance Materials Inc. | Ionically modified silicones, compositions, and medical devices formed therefrom |
US10678067B2 (en) | 2018-04-06 | 2020-06-09 | Vance M. Thompson | Tear shaping for refractive correction |
WO2021038279A1 (en) * | 2019-08-30 | 2021-03-04 | Sia Medhydrogel | A method for obtaining ion-exchange polymeric hydrogels for eye treatment and hydrogel lenses thereof |
KR102357782B1 (ko) * | 2020-04-06 | 2022-02-04 | 포항공과대학교 산학협력단 | 약물 충진 콜레스테롤-히알루론산 고분자 마이셀이 함유된 약물 방출 콘택트렌즈 |
CN111481513B (zh) * | 2020-04-20 | 2021-07-23 | 芜湖荣灿医药材料科技有限公司 | 缓释微球药物递送系统及其制备方法 |
CN112618480B (zh) * | 2020-11-10 | 2022-07-12 | 南昌大学 | 一种眼部药物递送体系的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3786812A (en) * | 1972-03-10 | 1974-01-22 | C Neefe | Contact lens for olar drug delivery |
US3937680A (en) * | 1973-05-29 | 1976-02-10 | Global Vision, Inc. | Hydrophilic gel terpolymers from hydrophilic n-vinyl monomers, hydroxyalkyl acrylates or methacrylates and polymerizable unsaturated carboxylic acids |
US3957049A (en) * | 1973-10-09 | 1976-05-18 | Neefe Charles W | Rechargeable drug delivery method |
US4254509A (en) * | 1979-04-09 | 1981-03-10 | Tennant Jerald L | Accommodating intraocular implant |
US4484922A (en) * | 1981-06-25 | 1984-11-27 | Rosenwald Peter L | Occular device |
US4668506A (en) * | 1985-08-16 | 1987-05-26 | Bausch & Lomb Incorporated | Sustained-release formulation containing and amino acid polymer |
CA2009668A1 (en) * | 1989-02-16 | 1990-08-16 | Ashok R. Thakrar | Colored contact lenses and method of making same |
US5723131A (en) * | 1995-12-28 | 1998-03-03 | Johnson & Johnson Vision Products, Inc. | Contact lens containing a leachable absorbed material |
JPH10339857A (ja) * | 1997-06-05 | 1998-12-22 | Menicon Co Ltd | 薬剤徐放性コンタクトレンズの製法およびそれによってえられた薬剤徐放性コンタクトレンズ |
US6410045B1 (en) * | 1999-02-22 | 2002-06-25 | Clyde Lewis Schultz | Drug delivery system for antiglaucomatous medication |
US20020141760A1 (en) * | 2001-03-29 | 2002-10-03 | Resnick Joseph A. | Transverse reflective-protective contact eye lenses and coating for conventional face-mounted apparatus, manufacturing method and kit |
-
2003
- 2003-06-05 AU AU2003248624A patent/AU2003248624B2/en not_active Ceased
- 2003-06-05 US US10/454,836 patent/US7638137B2/en active Active
- 2003-06-05 WO PCT/US2003/017736 patent/WO2003103549A1/en active Application Filing
- 2003-06-05 EP EP03757353A patent/EP1534202B1/en not_active Expired - Lifetime
- 2003-06-05 KR KR1020047019648A patent/KR20050037992A/ko not_active Application Discontinuation
- 2003-06-05 JP JP2004510672A patent/JP4448441B2/ja not_active Expired - Fee Related
- 2003-06-05 AT AT03757353T patent/ATE424795T1/de not_active IP Right Cessation
- 2003-06-05 CN CNB038188988A patent/CN100369593C/zh not_active Expired - Fee Related
- 2003-06-05 DE DE60326597T patent/DE60326597D1/de not_active Expired - Lifetime
- 2003-06-05 CA CA002487940A patent/CA2487940C/en not_active Expired - Fee Related
- 2003-06-05 BR BR0311585-2A patent/BR0311585A/pt not_active IP Right Cessation
-
2006
- 2006-01-10 HK HK06100396A patent/HK1080349A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20040096477A1 (en) | 2004-05-20 |
US7638137B2 (en) | 2009-12-29 |
EP1534202B1 (en) | 2009-03-11 |
EP1534202A4 (en) | 2006-04-12 |
WO2003103549A1 (en) | 2003-12-18 |
JP2005528185A (ja) | 2005-09-22 |
DE60326597D1 (de) | 2009-04-23 |
EP1534202A1 (en) | 2005-06-01 |
CN100369593C (zh) | 2008-02-20 |
CA2487940A1 (en) | 2003-12-18 |
AU2003248624A1 (en) | 2003-12-22 |
CA2487940C (en) | 2009-09-22 |
AU2003248624B2 (en) | 2006-04-06 |
JP4448441B2 (ja) | 2010-04-07 |
HK1080349A1 (en) | 2006-04-28 |
KR20050037992A (ko) | 2005-04-25 |
CN1674841A (zh) | 2005-09-28 |
ATE424795T1 (de) | 2009-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0311585A (pt) | Sistema de fornecimento de drogas, método para administrar uma droga oftálmica a um paciente, kit, uso do mesmo, método para preparar o sistema de fornecimento de drogas, e, artigo de fabricação | |
BRPI0506983A (pt) | composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico | |
WO2004019999A3 (en) | Agent delivery particle | |
DE602005010733D1 (de) | Ophthalmische emulsion mit einem immunosuppressiven mittel | |
DE60334924D1 (de) | Anoteilchengrösse | |
IL173078A0 (en) | Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form | |
IL213838A0 (en) | A composition comprising microplasmin for use as a medicament for the eye | |
AR049927A1 (es) | Pelicula para cuidado oral | |
MXPA05011517A (es) | Dispositivo para el suministro de medicamentos oftalmicos. | |
ATE66809T1 (de) | Vorrichtung zur arzneistoffabgabe und verfahren zu ihrer herstellung. | |
DK1125577T3 (da) | Væskeformige medikamentindföringspræparater | |
CO5700698A2 (es) | Composiciones y metodos para el cuidado oral y personal | |
WO2003061578A3 (en) | Compositions for treatment or prevention of bioterrorism | |
AU2357202A (en) | Ion-strength independent sustained release pharmaceutical formulation | |
BRPI0406858A (pt) | Liberação controlada de agentes altamente solúveis | |
WO2004073651A3 (en) | Identifying inhibitors of intracellular protein fibrillization | |
AU5673399A (en) | Compositions and methods for treating intracellular infections | |
BR0215366A (pt) | Formulações transdérmicas adesivas de diclofenac sódico | |
DE60007074D1 (de) | Sulfatierte phosphatidylinositole, ihre herstellung und verwendung | |
Bhoi et al. | Therapeutic efficacy of moxifloxacin mucoadhesive hydrogel for bacterial keratitis | |
ATE376827T1 (de) | Solid darreichungsform enthaltend koffein | |
TH53082A3 (th) | องค์ประกอบและวิธีการของการเตรียมอนุภาคจุลภาคของสารที่ไม่ละลายน้ำ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (U Free format text: TRANSFERIDO DE: UNIVERSITY OF FLORIDA |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 4A,6A E 7A ANUIDADES |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2064 DE 27/07/2010. |